Literature DB >> 8335152

Protracted clinical course for patients with Canavan disease.

N Zelnik1, A S Luder, O N Elpeleg, V Gross-Tsur, N Amir, J A Hemli, A Fattal, S Harel.   

Abstract

Before the establishment of N-acetylaspartic aciduria due to aspartoacylase deficiency as the cause of Canavan disease, diagnosis was based on the characteristic clinical features and spongiform encephalopathy, a pathological response shared by a number of other unrelated conditions. Thus confusion exists in the literature about the phenotype of spongiform encephalopathy (Canavan disease), with reports of 'juvenile' and 'congenital' forms, as well as the classical infantile type. In this report, six of 22 patients with infantile-onset Canavan disease survived beyond six years of age. This phenotypical pattern might be the result of better medical management and care, rather than evidence of genetic heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335152     DOI: 10.1111/j.1469-8749.1993.tb11649.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  4 in total

1.  Investigation of the motor system in two siblings with Canavan's disease: a combined transcranial magnetic stimulation (TMS) - diffusion tensor imaging (DTI) study.

Authors:  V K Kimiskidis; Vasileios Papaliagkas; S Papagiannopoulos; D Zafeiriou; D Kazis; E Tsatsali-Foroglou; Z Kouvatsou; V Kapina; D Koutsonikolas; G Anogianakis; T Geroukis; S Bostantjopoulou
Journal:  Metab Brain Dis       Date:  2017-01-28       Impact factor: 3.584

2.  The frequency of the C854 mutation in the aspartoacylase gene in Ashkenazi Jews in Israel.

Authors:  O N Elpeleg; Y Anikster; V Barash; D Branski; A Shaag
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

3.  Long-term follow-up after gene therapy for canavan disease.

Authors:  Paola Leone; David Shera; Scott W J McPhee; Jeremy S Francis; Edwin H Kolodny; Larissa T Bilaniuk; Dah-Jyuu Wang; Mitra Assadi; Olga Goldfarb; H Warren Goldman; Andrew Freese; Deborah Young; Matthew J During; R Jude Samulski; Christopher G Janson
Journal:  Sci Transl Med       Date:  2012-12-19       Impact factor: 17.956

4.  Mutational analysis of aspartoacylase: implications for Canavan disease.

Authors:  Jeremy R Hershfield; Nagarajan Pattabiraman; Chikkathur N Madhavarao; M A Aryan Namboodiri
Journal:  Brain Res       Date:  2007-03-03       Impact factor: 3.252

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.